Last week, Osteoporosis Canada heard a news story that suggested that there is an increased risk of developing osteonecrosis of bone if you are taking a bisphosphonate medication for osteoporosis. […]

Osteoporosis Update Osteoporosis Update provides the most current, reliable information to support general practitioners and other health professionals involved in the daily clinical management of osteoporosis. Osteoporosis Canada is currently […]

We are aware of a recent Food and Drug Administration (FDA) publication that reports on the association between use of zoledronic acid (Aclasta) and renal impairment. 1 We recognize that […]

This webinar featured an expert panel and was intended for Healthcare Professionals on managing osteoporosis patients during COVID-19. View this thought-provoking discussion focusing on challenges and solutions for managing your […]

Introducing a fashion line inspired by the two million Canadians affected by osteoporosis TORONTO, Feb. 6, 2019  – Models clad in stylish bubble wrap strutted down the Toronto Fashion Week® x […]

A recently released Canadian research study confirms what has been shown in past preliminary studies; – inflammation of the eye as a possible side effect of bisphosphonate therapy is very […]

Vitamin D plays a significant role in building and maintaining healthy bones. In light of the current COVID-19 pandemic, the effects of vitamin D on the immune system are being […]

Register to view a series of IOF Capture the Fracture Webinars. These webinars are for healthcare professionals who want to learn more about Fracture Liaison Services.

FRAX In addition to femoral neck (hip) BMD, age, gender, fracture history and steroid use, FRAX also takes into account other clinical risk factors to calculate the absolute 10-year risk […]